124 related articles for article (PubMed ID: 742555)
21. Effects of dietary potassium and race on urinary excretion of kallikrein and aldosterone in man.
Horwitz D; Margolius HS; Keiser HR
J Clin Endocrinol Metab; 1978 Aug; 47(2):296-9. PubMed ID: 263797
[TBL] [Abstract][Full Text] [Related]
22. Serum dopamine-beta-hydroxylase activity in essential hypertension and in chronic renal failure with hypertension.
Aoki K; Tazumi K; Takikawa K
Jpn Circ J; 1975 Oct; 39(10):1111-4. PubMed ID: 1195506
[TBL] [Abstract][Full Text] [Related]
23. Sympathoadrenal activity and plasma glucose effects on plasma dopamine-beta-hydroxylase levels in rats.
Muñoz JA; Garcia-Estañ J; Salom MG; Quesada T; Miras Portugal MT
Clin Chim Acta; 1985 Nov; 152(3):243-52. PubMed ID: 4064332
[TBL] [Abstract][Full Text] [Related]
24. Lack of correlation between serum dopamine-beta-hydroxylase activity and blood pressure in middle-aged men.
Huttunen JK; Pispa J; Kumlin T; Mattila S; Naukkarinen V; Miettinen T
Hypertension; 1979; 1(1):47-52. PubMed ID: 544513
[TBL] [Abstract][Full Text] [Related]
25. Effects of kallidinogenase on urinary kallikrein excretion and plasma prostanoid concentrations in patients with essential hypertension.
Ogawa K; Ito T; Ban M; Motizuki M; Satake T
Experientia; 1986 Sep; 42(9):1014-5. PubMed ID: 3639011
[TBL] [Abstract][Full Text] [Related]
26. Urinary prostaglandins and kallikrein in essential hypertension.
Weber PC; Scherer B; Held E; Siess W; Stoffel H
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():259s-261s. PubMed ID: 396075
[TBL] [Abstract][Full Text] [Related]
27. Plasma dopamine-beta-hydroxylase activity in normal young men: its responsiveness to manipulation of sodium balance and upright posture.
Takishita S; Fukiyama K; Kumamoto K; Noda Y; Kawasaki T
Jpn Circ J; 1977 Aug; 41(8):895-901. PubMed ID: 909130
[TBL] [Abstract][Full Text] [Related]
28. Urinary excretion of renal prostaglandins, kallikrein, vasopressin and aldosterone in essential hypertension.
Favre L; Jornot L; Riondel A; Vallotton M
Clin Exp Hypertens A; 1985-1986; 7(12):1663-79. PubMed ID: 3869481
[TBL] [Abstract][Full Text] [Related]
29. Plasma and tissue kallikrein-kinin systems during acute administration of frusemide in normotensive and hypertensive humans.
Ohman KP; Karlberg BE
Clin Sci (Lond); 1991 Sep; 81(3):305-11. PubMed ID: 1655330
[TBL] [Abstract][Full Text] [Related]
30. A comparison of catecholamine concentrations and dopamine-beta-hydroxylase activities in plasma from normotensive subjects and from patients with essential hypertension at rest and during exercise.
Planz G; Gierlichs HW; Hawlina A; Planz R; Stephany W; Rahn KH
Klin Wochenschr; 1976 Jun; 54(12):561-9. PubMed ID: 940292
[TBL] [Abstract][Full Text] [Related]
31. Effect of ACTH administration on urinary kallikrein excretion in man.
Whitworth JA; van Leeuwen BH; Hannah MC; Scoggins BA; Thatcher R
Clin Exp Pharmacol Physiol; 1984; 11(1):87-90. PubMed ID: 6325055
[TBL] [Abstract][Full Text] [Related]
32. Effect of furosemide on urinary kallikrein excretion in patients with essential hypertension.
Seino M; Abe K; Irokawa N; Ito T; Yasujima M; Sakurai Y; Chiba S; Saito K; Ritz K; Kusaka T; Miyazaki S; Yoshinaga K
Tohoku J Exp Med; 1978 Mar; 124(3):197-203. PubMed ID: 635897
[TBL] [Abstract][Full Text] [Related]
33. Effects of orally administered glandular kallikrein on urinary kallikrein and prostaglandin excretion, plasma immunoreactive prostanoids and platelet aggregation in essential hypertension.
Ogawa K; Ito T; Ban M; Mochizuki M; Satake T
Klin Wochenschr; 1985 Apr; 63(7):332-6. PubMed ID: 3889484
[TBL] [Abstract][Full Text] [Related]
34. Decreased urinary kallikrein activity and elevated blood pressure normalized by orally applied kallikrein in essential hypertension.
Overlack A; Stumpe KO; Ressel C; Kolloch R; Zywzok W; Krück F
Klin Wochenschr; 1980 Jan; 58(1):37-42. PubMed ID: 6900133
[TBL] [Abstract][Full Text] [Related]
35. Effect of acute volume alterations on norepinephrine and dopamine-beta-hydroxylase in normotensive and hypertensive subjects.
Lake CR; Ziegler MG
Circulation; 1978 Apr; 57(4):774-8. PubMed ID: 630687
[TBL] [Abstract][Full Text] [Related]
36. Urinary kallikrein in normotensive subjects and in patients with essential hypertension.
Zschiedrich H; Fleckenstein P; Geiger R; Fink E; Sinterhauf K; Philipp T; Distler A; Wolff HP
Clin Exp Hypertens (1978); 1980; 2(3-4):693-708. PubMed ID: 7000466
[TBL] [Abstract][Full Text] [Related]
37. Urinary kallikrein and salt sensitivity in essential hypertensive males.
Ferri C; Bellini C; Carlomagno A; Perrone A; Santucci A
Kidney Int; 1994 Sep; 46(3):780-8. PubMed ID: 7996800
[TBL] [Abstract][Full Text] [Related]
38. Effect of oral potassium on urinary kallikrein excretion in essential hypertension.
Murakami E; Hiwada K; Kokubu T; Imamura Y
Adv Exp Med Biol; 1989; 247B():133-7. PubMed ID: 2610052
[TBL] [Abstract][Full Text] [Related]
39. Plasma dopamine-beta-hydroxylase in uremia--increase in enzyme activity after renal transplantation.
Wang DM; Sasse EA; Itskovitz HD; Piering WF; Kochar MS; Doumas BT
Clin Chim Acta; 1980 Feb; 101(2-3):241-9. PubMed ID: 6987013
[TBL] [Abstract][Full Text] [Related]
40. [Studies of the relationship between renin secretion and the sympathetic nervous system responsiveness in man (author's transl)].
Kunita H; Hata S; Okada F
Nihon Naibunpi Gakkai Zasshi; 1975 Aug; 51(8):635-43. PubMed ID: 1237420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
